Matches in SemOpenAlex for { <https://semopenalex.org/work/W2473900837> ?p ?o ?g. }
- W2473900837 abstract "New chemotherapeutic compounds are needed to combat multidrug-resistant Mycobacterium tuberculosis (Mtb), which remains a serious public-health challenge. Decaprenylphosphoryl-β-D-ribose 2'-epimerase (DprE1 enzyme) has been characterized as an attractive therapeutic target to address this urgent demand. Herein, we have identified a new class of DprE1 inhibitors benzothiazinethiones as antitubercular agents. Benzothiazinethione analogue SKLB-TB1001 exhibited excellent activity against Mtb in the Microplate Alamar blue assay and intracellular model, meanwhile SKLB-TB1001 was also highly potent against multi-drug resistant extensively and drug resistant clinical isolates. Importantly, no antagonism interaction was found with any two-drug combinations tested in the present study and the combination of SKLB-TB1001 with rifampicin (RMP) was proved to be synergistic. Furthermore, benzothiazinethione showed superb in vivo antitubercular efficacy in an acute Mtb infection mouse model, significantly better than that of BTZ043. These data combined with the bioavailability and safety profiles of benzothiazinethione indicates SKLB-TB1001 is a promising preclinical candidate for the treatment of drug-resistant tuberculosis." @default.
- W2473900837 created "2016-07-22" @default.
- W2473900837 creator A5000638427 @default.
- W2473900837 creator A5002925062 @default.
- W2473900837 creator A5005960203 @default.
- W2473900837 creator A5012582632 @default.
- W2473900837 creator A5018920527 @default.
- W2473900837 creator A5030490098 @default.
- W2473900837 creator A5031731944 @default.
- W2473900837 creator A5032443397 @default.
- W2473900837 creator A5050501022 @default.
- W2473900837 creator A5051066876 @default.
- W2473900837 creator A5059665113 @default.
- W2473900837 creator A5065562045 @default.
- W2473900837 creator A5085305761 @default.
- W2473900837 creator A5090403310 @default.
- W2473900837 date "2016-07-13" @default.
- W2473900837 modified "2023-10-14" @default.
- W2473900837 title "Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis" @default.
- W2473900837 cites W1538374398 @default.
- W2473900837 cites W1964232011 @default.
- W2473900837 cites W1967396133 @default.
- W2473900837 cites W1969586092 @default.
- W2473900837 cites W1972806716 @default.
- W2473900837 cites W1976256007 @default.
- W2473900837 cites W1977881210 @default.
- W2473900837 cites W1986288809 @default.
- W2473900837 cites W1987879445 @default.
- W2473900837 cites W1999706161 @default.
- W2473900837 cites W2001294037 @default.
- W2473900837 cites W2007163196 @default.
- W2473900837 cites W2014328552 @default.
- W2473900837 cites W2019636958 @default.
- W2473900837 cites W2030216118 @default.
- W2473900837 cites W2033290625 @default.
- W2473900837 cites W2045140218 @default.
- W2473900837 cites W2052500196 @default.
- W2473900837 cites W2066515010 @default.
- W2473900837 cites W2068372433 @default.
- W2473900837 cites W2075222652 @default.
- W2473900837 cites W2075926270 @default.
- W2473900837 cites W2079069326 @default.
- W2473900837 cites W2089068540 @default.
- W2473900837 cites W2092679747 @default.
- W2473900837 cites W2093350317 @default.
- W2473900837 cites W2099939307 @default.
- W2473900837 cites W2100613152 @default.
- W2473900837 cites W2106016791 @default.
- W2473900837 cites W2117987331 @default.
- W2473900837 cites W2120624590 @default.
- W2473900837 cites W2122171231 @default.
- W2473900837 cites W2122267877 @default.
- W2473900837 cites W2126576359 @default.
- W2473900837 cites W2126989272 @default.
- W2473900837 cites W2128057974 @default.
- W2473900837 cites W2128491529 @default.
- W2473900837 cites W2136016567 @default.
- W2473900837 cites W2149802681 @default.
- W2473900837 cites W2158658436 @default.
- W2473900837 cites W2159060192 @default.
- W2473900837 cites W2167692904 @default.
- W2473900837 cites W2170448556 @default.
- W2473900837 cites W2314762075 @default.
- W2473900837 cites W2320887812 @default.
- W2473900837 cites W2329733337 @default.
- W2473900837 cites W2340847980 @default.
- W2473900837 cites W2413114447 @default.
- W2473900837 cites W2949304244 @default.
- W2473900837 cites W4233680365 @default.
- W2473900837 doi "https://doi.org/10.1038/srep29717" @default.
- W2473900837 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4942819" @default.
- W2473900837 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27405961" @default.
- W2473900837 hasPublicationYear "2016" @default.
- W2473900837 type Work @default.
- W2473900837 sameAs 2473900837 @default.
- W2473900837 citedByCount "28" @default.
- W2473900837 countsByYear W24739008372017 @default.
- W2473900837 countsByYear W24739008372018 @default.
- W2473900837 countsByYear W24739008372019 @default.
- W2473900837 countsByYear W24739008372020 @default.
- W2473900837 countsByYear W24739008372021 @default.
- W2473900837 countsByYear W24739008372022 @default.
- W2473900837 countsByYear W24739008372023 @default.
- W2473900837 crossrefType "journal-article" @default.
- W2473900837 hasAuthorship W2473900837A5000638427 @default.
- W2473900837 hasAuthorship W2473900837A5002925062 @default.
- W2473900837 hasAuthorship W2473900837A5005960203 @default.
- W2473900837 hasAuthorship W2473900837A5012582632 @default.
- W2473900837 hasAuthorship W2473900837A5018920527 @default.
- W2473900837 hasAuthorship W2473900837A5030490098 @default.
- W2473900837 hasAuthorship W2473900837A5031731944 @default.
- W2473900837 hasAuthorship W2473900837A5032443397 @default.
- W2473900837 hasAuthorship W2473900837A5050501022 @default.
- W2473900837 hasAuthorship W2473900837A5051066876 @default.
- W2473900837 hasAuthorship W2473900837A5059665113 @default.
- W2473900837 hasAuthorship W2473900837A5065562045 @default.
- W2473900837 hasAuthorship W2473900837A5085305761 @default.
- W2473900837 hasAuthorship W2473900837A5090403310 @default.
- W2473900837 hasBestOaLocation W24739008371 @default.
- W2473900837 hasConcept C114851261 @default.